| 5A6N | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | GOL, PGO, U7E | enzyme |
| ||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | De Novo Fragment Design for Drug Discovery and Chemical Biology., Rodrigues T, Reker D, Welin M, Caldera M, Brunner C, Gabernet G, Schneider P, Walse B, Schneider G, Angew Chem Int Ed Engl. 2015 Oct 21. doi: 10.1002/anie.201508055. PMID:26486226 | ||||||||||||||
| Data retrieval |
![]() |
| View 5A6N in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |